COHANCE LIFESCIENCES
|
The Current P/E Ratio of COHANCE LIFESCIENCES is 312.46.
| Share Price | ₹478.0 | Oct 27,2026 |
| Market Cap | ₹18,288.3 Cr | |
| Earnings-TTM | ₹58.5 Cr | TTM-Consolidated Results |
| Price/Earnings | 312.46x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of COHANCE LIFESCIENCES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹18,288.3 Cr] as on Oct 27,2026
(/) Earnings [ ₹58.5 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 312.46x ]
Thus, for COHANCE LIFESCIENCES , the investors are currently willing to pay 312.46 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of COHANCE LIFESCIENCES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of COHANCE LIFESCIENCES over the last five years.
Historical PE (Price/Earnings) ratio chart of COHANCE LIFESCIENCES
PE Ratio Performance Analysis for COHANCE LIFESCIENCES
- COHANCE LIFESCIENCES 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 49.27x.
- COHANCE LIFESCIENCES 's operated at median p/e ratio of 57.37x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, COHANCE LIFESCIENCES 's p/e ratio peaked in Mar2026 at 64.45x.
- COHANCE LIFESCIENCES 's p/e ratio hit its five-year low in Mar2023 of 29.26x.
How does COHANCE LIFESCIENCES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| COHANCE LIFESCIENCES | 58.53 | 312.46 | 18,288.3 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 12,172.70 | 34.69 | 422,283.0 |
| DIVIS LABORATORIES LTD | 2,925.00 | 86.02 | 251,611.0 |
| TORRENT PHARMACEUTICALS LTD | 2,099.00 | 83.46 | 175,182.0 |
| CIPLA LTD | 2,868.29 | 38.02 | 109,063.0 |
| DR REDDYS LABORATORIES LTD | 2,759.70 | 39.47 | 108,926.0 |
| MANKIND PHARMA LTD | 2,249.69 | 45.91 | 103,286.0 |
| LUPIN LTD | 5,551.01 | 16.14 | 89,586.0 |
| ZYDUS LIFESCIENCES LTD | 4,492.20 | 25.91 | 116,409.0 |
| AUROBINDO PHARMA LTD | 3,712.74 | 25.31 | 93,959.2 |
| LAURUS LABS LTD | 1,090.76 | 106.00 | 115,616.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs COHANCE LIFESCIENCES 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 16.14x |
| Max industry PE | 312.46x |
| Median industry PE | 39.47x |
| Average industry PE | 73.94x |
You may also like the below Video Courses